3[4]Nieves Sopena and the Neunos 2000 Study Group.Study of multiple center about non-ICU patients with hospital-acquired pneumonia.CHEST,2005,127:213-219.
二级参考文献7
1Talon D,Mulin B,Rouget C,et al.Risks and routes for ventilatorassociated pneumonia with Pseudomonas aeruginosa[].American Journal of Respiratory and Critical Care Medicine.1998
2Baker AM,Meredith JW,Haponik EF.Pneumonia in intubated trauma patients.Microbiology and outcomes[].American Journal of Respiratory and Critical Care Medicine.1996
3George DL,Falk PS,Wunderink RG,et al.Epidemiology of ventilatoracquired pneumonia based on protected bronchoscopic sampling[].American Journal of Respiratory and Critical Care Medicine.1998
4Cook DJ,Walter SD,Cook RJ,et al.Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients[].Annals of Internal Medicine.1998
5Heyland DK,Cook DJ,Griffith L,et al.The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient.The Canadian Critical Trials Group[].American Journal of Respiratory and Critical Care Medicine.1999
6Papazian L,Bregeon F,Thirion X,et al.Effect of ventilator-associated pneumonia on mortality and morbidity[].American Journal of Respiratory and Critical Care Medicine.1996
7Kollerf M.Ventilator-associated pneumonia.A multivariate analysis[].The Journal of The American Medical Association.1993
3Badr MA, Ali YF, Albanna EA,et al. Ventilator assosiated pneu-monia in critically-ill neonates adimitted to neonatal intensive careunit, zagazig university hospitals [ J ]. Iran J Pediatr, 2011, 21?4) :418424.
4肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2012:435439.
5Mokra D, Drgova A, Kopincova J, et al. Anti - inflammatory treat-ment in dysfunction of pulmonary surfactant in meconium-inducedacute lung injury[ J]. Adv Exp Biol Bio,2013 ,756 : 189-196.
6Shah SS,Ohlsson A,Halliday HL,et al. Inhaled versus systemiccorticosteroids for preventing chronic lung disease in ventilatedvery low birth weight preterm neonates [ DB/ OL ]. Cochrane Data-base Syst Rev,2012,5:CD002058.
7Onland W,Offringa M,van Kaam A. Late (^7 days) inhala-tion corticosteroids to reduce bronchopulmonary dysplasia in pre-term infants[ DB/OL]. Cochrane Database Syst Reviews, 2012 ,4:CD002311.
8Dolovich MB, Ahrens RC , Hess DR, et al. Device selection andoutcomes of aerosol therapy : Evidence-based guidelines : AmericanCollege of Chest Physicians/American College of Asthma,Aller-gy, and Immunology [ J]. Chest ,2005,127(1) :335-371.
9Barnes PJ. Inhaled glucocorticoids for asthma[ J]. N Engl J Med,1995,332(13):868-875.
10Hvizdos KM, Jarvis B. Budesonide inhalation suspension: a re-view of its use in infants,children and adults with inflammatoryrespiratory disorders[ J]. Drugs,2000,60(5 ) :1141-1178.
